WALTHAM,
Mass., July 25, 2024 /PRNewswire/ -- Syndax
Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical
company developing an innovative pipeline of cancer therapies,
today announced that it will report its second quarter 2024
financial results and provide a business update on Thursday, August 1, 2024.
In connection with the earnings release, Syndax's
management will host a conference call and live audio webcast at
4:30 p.m. ET on Thursday, August 1,
2024 to discuss the Company's financial results and provide
a business update.
The live audio webcast and accompanying slides
may be accessed through the Events & Presentations page in
the Investors section of the Company's website. Alternatively, the
conference call may be accessed through the following:
Conference ID: Syndax2Q24
Domestic Dial-in Number: 800-590-8290
International Dial-in Number: 240-690-8800
Live webcast:
https://www.veracast.com/webcasts/syndax/events/SNDX2Q24.cfm
For those unable to participate in the conference
call or webcast, a replay will be available on the Investors
section of the Company's website at www.syndax.com approximately 24
hours after the conference call and will be available for 90 days
following the call.
About Syndax
Syndax Pharmaceuticals is a clinical stage
biopharmaceutical company developing an innovative pipeline of
cancer therapies. Highlights of the Company's pipeline include
revumenib, a highly selective menin inhibitor, and axatilimab, a
monoclonal antibody that blocks the CSF-1 receptor. For more
information, please visit www.syndax.com or follow the Company
on X (formerly Twitter) and LinkedIn.
Syndax Contact
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827
SNDX-G
View original
content:https://www.prnewswire.com/news-releases/syndax-to-announce-second-quarter-2024-financial-results-and-host-conference-call-and-webcast-on-august-1-2024-302206073.html
SOURCE Syndax Pharmaceuticals, Inc.